Cimeio Therapeutics AG
BASEL, CH· latest recorded location
CIMEIO THERAPEUTICS AG is named on 0 US grants and 4 published applications in this corpus. Its most frequent classification is C07K (Peptides).
- Granted patents
- 0
- Published applications
- 4
- Inventors
- 19
- Granted in 2026 so far
- 0
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2025 | 0 | 2 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 4 documents
Recent patents
No granted patents yet.
- Antibodies targeting cd1173 Sep 2026US 2026/0258124 A1
- Discernible cell surface protein variants of cd33 for use in cell therapy20 Aug 2026US 2026/0242735 A1
- Discernible cell surface protein variants for use in cell therapy23 Oct 2025US 2025/0326818 A1
- Discernible cell surface protein variants of cd117 for use in cell therapy20 Feb 2025US 2025/0057951 A1
Most cited
By later US patents
None of its patents has been cited by a later US patent yet.